Rodríguez Gil, A., Escamilla Gómez, V., Nufer, M., Andújar Sánchez, F., Lopes Ramos, T., Bejarano García, J. A., . . . Pérez Simón, J. A. (2022). Combined treatment of graft versus host disease using donor regulatory T cells and ruxolitinib.
Citación estilo ChicagoRodríguez Gil, Alfonso, et al. Combined Treatment of Graft Versus Host Disease Using Donor Regulatory T Cells and Ruxolitinib. 2022.
Cita MLARodríguez Gil, Alfonso, et al. Combined Treatment of Graft Versus Host Disease Using Donor Regulatory T Cells and Ruxolitinib. 2022.
Precaución: Estas citas no son 100% exactas.